Efficacy of confronting smokers with airflow limitation for smoking cessation
Authors:
- D. KotzDKD. Kotz
- G. WesselingGWG. Wesseling
- M. J. H. HuibersMHM. J. H. Huibers
- O. C. P. van SchayckOSO. C. P. van Schayck
- 7 January 2009
- journal article
- research article
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 33 (4) , 754-762
Abstract
The objective of the present study was to test whether confronting smokers with previously undetected chronic obstructive pulmonary disease (COPD) increases the rate of smoking cessation.In total, 296 smokers with no prior diagnosis of COPD were detected with mild-to-moderate airflow limitation by means of spirometry and randomly allocated to: confrontational counselling by a nurse with nortriptyline for smoking cessation (experimental group); regular counselling by a nurse with nortriptyline (control group 1); or “care as usual” for smoking cessation by the general practitioner (control group 2). Only the experimental group was confronted with their abnormal spirometry (mean forced expiratory volume in one second (FEV1) post-bronchodilator 80.5% predicted, mean FEV1/forced vital capacity post-bronchodilator 62.5%).There was no difference in cotinine-validated prolonged abstinence rate between the experimental group (11.2%) and control group 1 (11.6%) from week 5–52 (odds ratio (OR) 0.96, 95% confidence interval (CI) 0.43–2.18). The abstinence rate was approximately twice as high in the experimental group compared with control group 2 (5.9%), but this difference was not statistically significant (OR 2.02, 95% CI 0.63–6.46).The present study did not provide evidence that the confrontational approach increases the rate of long-term abstinence from smoking compared with an equally intensive treatment in which smokers were not confronted with spirometry. The high failure rates (≥88%) highlight the need for treating tobacco addiction as a chronic relapsing disorder.Keywords
This publication has 35 references indexed in Scilit:
- Common predictors of smoking cessation in clinical practiceRespiratory Medicine, 2008
- Principles of confrontational counselling in smokers with chronic obstructive pulmonary disease (COPD)Medical Hypotheses, 2008
- Antidepressants for smoking cessation2007
- Efficacy of Bupropion and Nortriptyline for Smoking Cessation Among People at Risk for or With Chronic Obstructive Pulmonary DiseaseArchives of internal medicine (1960), 2005
- Burden and clinical features of chronic obstructive pulmonary disease (COPD)The Lancet, 2004
- Smoking cessation in patients with chronic obstructive pulmonary disease: a double-blind, placebo-controlled, randomised trialThe Lancet, 2001
- Effectiveness of a Minimal Contact Smoking Cessation Program for Dutch General Practitioners: A Randomized Controlled TrialPreventive Medicine, 2001
- Alternative projections of mortality and disability by cause 1990–2020: Global Burden of Disease StudyThe Lancet, 1997
- Effects of Smoking Intervention and the Use of an Inhaled Anticholinergic Bronchodilator on the Rate of Decline of FEV1JAMA, 1994
- Randomized consent designs for clinical trials: An updateStatistics in Medicine, 1990